Chemotherapy with acute leukemia as secondary diagnosis

DRG MCC CC SDX Acute Leukemia High Dose Chemo Agent
837 Yes n/a Yes n/a
837 Yes n/a No Yes
838 No Yes Yes No
838 No n/a No Yes
839 No No Yes No

Details

DRG 837 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC
DRG 838 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT
DRG 839 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC
CHEMOTHERAPY
PRINCIPAL DIAGNOSIS
Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm
Z51.11 Encounter for antineoplastic chemotherapy
Z51.12 Encounter for antineoplastic immunotherapy
ACUTE LEUKEMIA
SECONDARY DIAGNOSIS
C91.00 Acute lymphoblastic leukemia not having achieved remission
C91.01 Acute lymphoblastic leukemia, in remission
C91.02 Acute lymphoblastic leukemia, in relapse
C92.00 Acute myeloblastic leukemia, not having achieved remission
C92.01 Acute myeloblastic leukemia, in remission
C92.02 Acute myeloblastic leukemia, in relapse
C92.40 Acute promyelocytic leukemia, not having achieved remission
C92.41 Acute promyelocytic leukemia, in remission
C92.42 Acute promyelocytic leukemia, in relapse
C92.50 Acute myelomonocytic leukemia, not having achieved remission
C92.51 Acute myelomonocytic leukemia, in remission
C92.52 Acute myelomonocytic leukemia, in relapse
C92.60 Acute myeloid leukemia with 11q23-abnormality not having achieved remission
C92.61 Acute myeloid leukemia with 11q23-abnormality in remission
C92.62 Acute myeloid leukemia with 11q23-abnormality in relapse
C92.A0 Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
C92.A1 Acute myeloid leukemia with multilineage dysplasia, in remission
C92.A2 Acute myeloid leukemia with multilineage dysplasia, in relapse
C93.00 Acute monoblastic/monocytic leukemia, not having achieved remission
C93.01 Acute monoblastic/monocytic leukemia, in remission
C93.02 Acute monoblastic/monocytic leukemia, in relapse
C94.00 Acute erythroid leukemia, not having achieved remission
C94.01 Acute erythroid leukemia, in remission
C94.02 Acute erythroid leukemia, in relapse
C95.00 Acute leukemia of unspecified cell type not having achieved remission
C95.01 Acute leukemia of unspecified cell type, in remission
C95.02 Acute leukemia of unspecified cell type, in relapse
HIGH DOSE CHEMO AGENT
3E03002* Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach
3E03302* Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach
3E04002* Introduction of High-dose Interleukin-2 into Central Vein, Open Approach
3E04302* Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach
3E05002* Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach
3E05302* Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach
3E06002* Introduction of High-dose Interleukin-2 into Central Artery, Open Approach
3E06302* Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach
3E0R302* Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach
3E0S302* Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach